One-A-Day Heart Polypill To Be Tested In New International Trial
Posted May 31 2010 8:03pm
Researchers will be exploring whether a new, very low cost, one-a-day combined ‘polypill’ could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
Cardiovascular disease is the world’s biggest killer and the leading cause of loss of healthy life years.
The new ‘Red Heart Pill’ contains low-dose aspirin, a statin and two blood pressure-lowering medicines in a single polypill. It is expected to be substantially cheaper than existing medications to combat cardiovascular problems.
Researchers are now recruiting 2,000 volunteers who are at high risk of heart attack or stroke, or who have already had such a cardiovascular event, for a two-year trial of the Red Heart Pill.
Researchers will be exploring whether a new, very low cost, one-a-day combined ‘polypill’ could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
Cardiovascular disease is the world’s biggest killer and the leading cause of loss of healthy life years.
The new ‘Red Heart Pill’ contains low-dose aspirin, a statin and two blood pressure-lowering medicines in a single polypill. It is expected to be substantially cheaper than existing medications to combat cardiovascular problems.
Researchers are now recruiting 2,000 volunteers who are at high risk of heart attack or stroke, or who have already had such a cardiovascular event, for a two-year trial of the Red Heart Pill.